Market Place
Sourcing Support
Clearmind Medicine Files US Patent For Metabolic Syndrome Treatment
16 Jul 2024 //
GLOBENEWSWIRE
Full Alliance Subsidiary DynaMAXX Launches PRiVIVE™ Topical Serum
18 Jun 2024 //
ACCESSWIRE
FDA & Health Canada Clear IND for FSD to Proceed with PII Trial of FSD201
06 Sep 2022 //
BUSINESSWIRE
Lucid Psycheceuticals Files for Patent On Formulations of Palmitoylethanolamide
13 Jul 2022 //
BUSINESSWIRE
FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial
24 Aug 2021 //
BUSINESSWIRE
Advanced Orthomolecular Research Launches P.E.A. Endocannabinoid
22 Nov 2019 //
PR NEWSWIRE
Therapix Biosciences Announces +ve Topline Results From PhIIa Trial of THX-110
13 Nov 2019 //
PR NEWSWIRE
Therapix Biosc Announces 1st Pt Enrollment in Clinical at Assuta Medical Center
05 Jun 2018 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.